NEO
CFO
2026-03-02–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
SEC 8-K
2026-03-02–present
Start not stated–2026-04-14
Recorded roles and earnings-call appearances connecting this person to public companies.
NEO
CFO
2026-03-02–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Neogenomics Inc (NEO) | Chief Financial Officer | $540,346 | $3,482,409 |
| 2023 | Neogenomics Inc (NEO) | Chief Financial Officer | $525,000 | $3,547,358 |
| 2022 | Neogenomics Inc (NEO) | Chief Financial Officer | $16,154 | $3,266,154 |
Earnings-call appearances and filed executive appointments or departures, newest first.